TrialAnnals of the rheumatic diseases2016

The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.

Tatsuya Atsumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.